To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema
Clinical trial NCT01846299 · COMPLETED
Trial details
- NCT number
- NCT01846299
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2015-09-01
- Enrollment
- 181
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.